220 related articles for article (PubMed ID: 18425331)
1. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP
Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331
[TBL] [Abstract][Full Text] [Related]
2. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
3. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.
Kraemer K; Fuessel S; Meye A
Methods Mol Biol; 2007; 405():9-22. PubMed ID: 18369813
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
Ning S; Fuessel S; Kotzsch M; Kraemer K; Kappler M; Schmidt U; Taubert H; Wirth MP; Meye A
Int J Oncol; 2004 Oct; 25(4):1065-71. PubMed ID: 15375557
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
Fuessel S; Herrmann J; Ning S; Kotzsch M; Kraemer K; Schmidt U; Hakenberg OW; Wirth MP; Meye A
Cancer Lett; 2006 Feb; 232(2):243-54. PubMed ID: 16458121
[TBL] [Abstract][Full Text] [Related]
7. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Cancer Chemother Pharmacol; 2006 Feb; 57(3):328-34. PubMed ID: 16028098
[TBL] [Abstract][Full Text] [Related]
8. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
Hou JQ; He J; Wang XL; Wen DG; Chen ZX
Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
10. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
11. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model.
Yamanaka K; Gleave M; Muramaki M; Hara I; Miyake H
Oncol Rep; 2005 May; 13(5):885-90. PubMed ID: 15809754
[TBL] [Abstract][Full Text] [Related]
12. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
[TBL] [Abstract][Full Text] [Related]
14. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of telomerase activity in human promyelocytic cell line using RNA interference.
Miri-Moghaddam E; Deezagi A; Soheili ZS
Ann Hematol; 2009 Dec; 88(12):1169-76. PubMed ID: 19415276
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Gao XD; Chen YR
Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
[TBL] [Abstract][Full Text] [Related]
17. Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.
Kraemer K; Schmidt U; Fuessel S; Herr A; Wirth MP; Meye A
Int J Cancer; 2006 Sep; 119(6):1276-84. PubMed ID: 16615118
[TBL] [Abstract][Full Text] [Related]
18. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity.
Qian X; Cheng J; Chen A; Wang Y; Tao Y; Cao J; Feng Z
Oncol Rep; 2008 Feb; 19(2):575-81. PubMed ID: 18202810
[TBL] [Abstract][Full Text] [Related]
20. [Prospects for molecular research in urological oncology: bladder cancer].
Koshida K; Imao T; Ito H; Miyagi T; Konaka H; Mizokami A; Egawa M; Namiki M
Hinyokika Kiyo; 2001 Nov; 47(11):815-8. PubMed ID: 11771177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]